NVR BCR (Tasigna 150 mg)

Generic Name: nilotinib

Pill imprint NVR BCR has been identified as Tasigna 150 mg.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for NVR BCR

Tasigna
Generic Name:
nilotinib
Imprint:
NVR
BCR
Strength:
150 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0592
Inactive Ingredients:
silicon dioxide
crospovidone
gelatin
lactose monohydrate
magnesium stearate
ferric oxide red
titanium dioxide
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)